A Phase 1/2 Study to Evaluate the Safety and Efficacy of Dibotatug (DR-01) in Adults With Bone Marrow Failure Syndromes | MicrobiomeTrials← Back to trialsNCT07712562
A Phase 1/2 Study to Evaluate the Safety and Efficacy of Dibotatug (DR-01) in Adults With Bone Marrow Failure Syndromes
RecruitingPHASE1, PHASE2INTERVENTIONAL
Trial Details
Start: 2026-08Est. Completion: 2029-04
Enrollment target: 60 participants Locations- Dren Investigational Site, Duarte, California, United States
- Dren Investigational Site, Palo Alto, California, United States
- Dren Investigational Site, Miami, Florida, United States
- Dren Investigational Site, Atlanta, Georgia, United States
- Dren Investigational Site, New York, New York, United States
- Dren Investigational Site, Cleveland, Ohio, United States
- Dren Investigational Site, Columbus, Ohio, United States
- Dren Investigational Site, Houston, Texas, United States
- Dren Investigational Site, Fairfax, Virginia, United States
- Dren Investigational Site, Seattle, Washington, United States
Other microbiome trials you might be interested in
MelanomaLi-Fraumeni SyndromePulmonary BlastomaChordomaCongenital Bone Marrow Failure SyndromesCostello SyndromeFanconi AnemiaCFC Syndrome (CFCS)Legius SyndromeRASopathies
Background:
Clinical Genetics Branch (CGB) researchers study individuals and populations at high genetic risk of cancer…
Rockville, United StatesEst. completion Jan 1, 2035
Diamond Blackfan AnemiaDyskeratosis Congenita
Fanconi Anemia
Shwachman Diamond Syndrome
Inherited Bone Marrow Failure Syndrome, Aplastic Anemia
Background:
A prospective cohort of Inherited Bone Marrow Failure Syndrome (IBMFS) will provide new information regardi…
B Acute Lymphoblastic Leukemia, Philadelphia Chromosome NegativeRecurrent B Acute Lymphoblastic LeukemiaRefractory B Acute Lymphoblastic Leukemia
This phase II trial studies how well inotuzumab ozogamicin and blinatumomab with or without ponatinib work in treating p…
Birmingham, United StatesEst. completion Feb 1, 2027